Open AccessAssociation of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury
Author(s) -
Sandeep Brar,
Ye Feng,
Matthew T. James,
Brenda R. Hemmelgarn,
Scott Klarenbach,
Neesh Pannu
Publication year - 2018
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2018.4749
Subject(s) - medicine , acute kidney injury , kidney disease , renal function , creatinine , retrospective cohort study , angiotensin converting enzyme , cohort , population , cohort study , renal replacement therapy , blood pressure , environmental health
Patients with acute kidney injury (AKI) are at an increased long-term risk of death. Effective strategies that improve long-term outcomes in patients with AKI are unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom